• Protean BioDiagnostics Lung HDPCR™ for Non-Small Cell Lung Cancer (NSCLC)
  • Endometrial Carcinoma Gene Mutation Panel, NGS
  • Myelin Oligodendrocyte Glycoprotein (MOG), Antibody, Serum
  • Tramadol, Urine
  • PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) Gene Mutation Analysis
  • Carbamazepine Profile, Serum
  • Hepatitis B Core Antibody, IgM
  • Folic Acid (Folate), RBC
  • Aminolevulinic Acid, Urine
  • Eurofins TRAC® Test for Monitoring Kidney Transplant Health
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Additional ICD10
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...